← All trials
NCT05682443
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 6, 2023
- Primary completion
- Jun 30, 2026
- Completion date
- Jun 30, 2027
- First posted
- Jan 12, 2023
- Last posted
- Dec 8, 2023
- Enrollment
- 144
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- OncoC4, Inc.Lead sponsor
- Columbia UniversityOverall official - principal investigator
- New York UniversityOverall official - principal investigator
- New York UniversityOfficial
- Columbia UniversityOfficial
- Prostate Cancer Clinical Trials ConsortiumCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.